Short interest in Qualigen Therapeutics Inc (NASDAQ:QLGN) decreased during the last reporting period, falling from 97.82K to 87.33K. This put 11.87% of the company's publicly available shares short.

Short interest for Qualigen Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Qualigen Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 31.39K shares traded per day, it would take 2.78 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.